As of May 26
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for SkyePharma PLC have a median target of 7.26, with a high estimate of 7.26 and a low estimate of 7.26. The median estimate represents a +59.66% increase from the last price of 4.55.
The current consensus among 1 polled investment analysts is to Buy stock in SkyePharma PLC. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.